Encompass Health Corporation
EHC
$99.25
-$0.42-0.42%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.91% | 11.15% | 10.86% | 11.40% | 10.41% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.91% | 11.15% | 10.86% | 11.40% | 10.41% |
| Cost of Revenue | 11.41% | 11.05% | 10.37% | 10.02% | 8.59% |
| Gross Profit | 12.63% | 11.30% | 11.55% | 13.40% | 13.10% |
| SG&A Expenses | 3.29% | 7.13% | 11.54% | 24.18% | 23.44% |
| Depreciation & Amortization | 9.38% | 9.21% | 7.14% | 12.21% | 12.44% |
| Other Operating Expenses | 11.61% | 10.87% | 10.05% | 8.10% | 7.26% |
| Total Operating Expenses | 10.80% | 10.65% | 10.17% | 10.61% | 9.44% |
| Operating Income | 18.13% | 13.93% | 14.74% | 15.93% | 16.12% |
| Income Before Tax | 23.45% | 20.18% | 21.35% | 31.29% | 34.69% |
| Income Tax Expenses | 13.62% | 18.05% | 21.71% | 27.86% | 32.07% |
| Earnings from Continuing Operations | 26.19% | 20.75% | 21.25% | 32.28% | 35.44% |
| Earnings from Discontinued Operations | 76.67% | -134.00% | 44.59% | -29.47% | -182.19% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -26.94% | -19.98% | -17.01% | -14.10% | -17.71% |
| Net Income | 29.46% | 19.39% | 27.27% | 38.94% | 29.89% |
| EBIT | 18.13% | 13.93% | 14.74% | 15.93% | 16.12% |
| EBITDA | 15.75% | 12.65% | 12.65% | 14.90% | 15.09% |
| EPS Basic | 28.90% | 18.90% | 26.77% | 38.39% | 29.17% |
| Normalized Basic EPS | 21.63% | 19.91% | 22.71% | 38.58% | 42.23% |
| EPS Diluted | 28.28% | 18.30% | 26.09% | 37.77% | 29.11% |
| Normalized Diluted EPS | 21.05% | 19.27% | 21.97% | 37.76% | 41.54% |
| Average Basic Shares Outstanding | 0.43% | 0.35% | 0.33% | 0.30% | 0.25% |
| Average Diluted Shares Outstanding | 0.91% | 0.89% | 0.94% | 0.92% | 0.77% |
| Dividend Per Share | 6.67% | 3.33% | 0.00% | -17.81% | -30.23% |
| Payout Ratio | -0.20% | -0.16% | -0.35% | -0.49% | -0.53% |
